Skip to main content

Find Clinical Trials

Home
Conditions
Carcinoma, Neuroendocrine

Clinical trial condition

Carcinoma, Neuroendocrine

Explore clinical trials studying Carcinoma, Neuroendocrine. Study availability and eligibility vary by location and protocol.

112 public trials 35 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Neuroendocrine trial results

Recruiting

Efficacy and Safety Evaluation of Tarlatamab in Advanced Extrapulmonary Neuroendocrine Carcinoma Patients

NCT06893783

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +10 more
Locations: Asan Medical Center Seoul, South Korea

Samsung Medical Center Seoul, South Korea

Seoul National University Hospital Seoul, South Korea

Yonsei Severance Hospital Seoul, South Korea

View Trial Details

Recruiting

Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma

NCT05978284

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +18 more
Locations: Henan Cancer Hospital Zhengzhou, Henan, China

View Trial Details

Recruiting

ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma

NCT07038096

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +18 more
Locations: Sun Yat-sen University Cancer Center Guanzhou, Guangdong, China

View Trial Details

Recruiting

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

NCT06943521

Conditions: Adenocarcinoma, Adnexal Diseases, Biliary Tract Cancer, +75 more
Locations: University of Southern California Los Angeles, California, United States

START Midwest Grand Rapids, Michigan, United States

The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

The University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI

NCT06333314

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +28 more
Locations: Institut de Cancérologie de l'Ouest Angers, France

Institut du Cancer Avignon-Provence Avignon, France

CHU Jean Minjoz Besançon, France

CHU Morvan Brest, France

View all 22 locations

View Trial Details

Recruiting

Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer

NCT06283719

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +18 more
Locations: Shanghai Chest Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary

NCT04325425

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
Locations: Chu de Caen Caen, France

Chu Dijon Bourgogne Dijon, France

Institut de Cancérologie de Bourgogne Dijon, France

Chu de Limoges - Dupuytren Limoges, France

View Trial Details

Recruiting

Ivonescimab in the Treatment of Multiple Advanced Tumors

NCT06683846

Conditions: Adenocarcinoma, Adrenal Cortical Cancer, Angiomyolipoma, +56 more
Locations: Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Efficacy of Neoadjuvant Chemotherapy in Terms of DFS in Patients With Localized Digestive Neuroendocrine Carcinomas

NCT04268121

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +14 more
Locations: CHU Amiens - Hôpital Sud Amiens, France

CHU Jean Minjoz Besançon, France

Hôpital Beaujon Clichy, France

CHU Dijon Dijon, France

View all 14 locations

View Trial Details

Recruiting

Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN)

NCT04464122

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +11 more
Locations: Andrea M Isidori Rome, Italy

View Trial Details